LY6K as a Target in Bladder Cancer
Author Information
Author(s): Matsuda R, Enokida H, Chiyomaru T, Kikkawa N, Sugimoto T, Kawakami K, Tatarano S, Yoshino H, Toki K, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M
Primary Institution: Kagoshima University
Hypothesis
The study aims to identify a novel molecular target based on chromosomal alterations and gene expression analyses in bladder cancer.
Conclusion
The oncogenic LY6K gene located at 8q24.3 may play a significant role in the development of bladder cancer.
Supporting Evidence
- LY6K mRNA expression was significantly higher in 91 bladder cancer samples than in 37 normal bladder epithelium samples.
- High LY6K expression was validated by fluorescence in situ hybridization due to gene amplification.
- Knockdown of LY6K resulted in significant decreases in cell growth, migration, and invasion in bladder cancer cell lines.
Takeaway
Researchers found that a gene called LY6K is more active in bladder cancer cells than in normal cells, which might help in developing new treatments.
Methodology
The study used high-resolution array-comparative genomic hybridization and real-time reverse transcription PCR to analyze gene expression in bladder cancer cell lines and clinical samples.
Limitations
The study did not find a relationship between LY6K expression and clinicopathological parameters.
Participant Demographics
91 bladder cancer patients and 37 normal bladder epithelium samples were analyzed.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI 12.4–26.8
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website